Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions.

The commercial availability of combined magnetic resonance imaging (MRI)/positron emission tomography (PET) scanners for clinical use has increased demand for easily prepared agents which offer signal or contrast in both modalities. Herein we describe a new class of silica coated iron-oxide nanorods (NRs) coated with polyethylene glycol (PEG) and/or a tetraazamacrocyclic chelator (DO3A). Studies of the coated NRs validate their composition and confirm their properties as in vivo T2 MRI contrast agents. Radiolabelling studies with the positron emitting radioisotope gallium-68 (t1/2 = 68 min) demonstrate that, in the presence of the silica coating, the macrocyclic chelator was not required for preparation of highly stable radiometal-NR constructs. In vivo PET-CT and MR imaging studies show the expected high liver uptake of gallium-68 radiolabelled nanorods with no significant release of gallium-68 metal ions, validating our innovation to provide a novel simple method for labelling of iron oxide NRs with a radiometal in the absence of a chelating unit that can be used for high sensitivity liver imaging.

[1]  Mingyuan Gao,et al.  Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications , 2009 .

[2]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[3]  Nicholas J Long,et al.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.

[4]  R. Tavaré,et al.  Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands. , 2011, Chemical communications.

[5]  J. Kjems,et al.  Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. , 2009, ACS nano.

[6]  Jean-Luc Coll,et al.  Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. , 2009, Small.

[7]  Samir Mitragotri,et al.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.

[8]  M. Port,et al.  Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota)-characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence , 2004, Chemistry.

[9]  Jinwoo Cheon,et al.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. , 2008, Angewandte Chemie.

[10]  M. Toprak,et al.  Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities. , 2012, Contrast media & molecular imaging.

[11]  Chris Orvig,et al.  Matching chelators to radiometals for radiopharmaceuticals. , 2014, Chemical Society reviews.

[12]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[13]  Shuang Liu,et al.  Selectivity of Potentially Hexadentate Amine Phenols for Ga3+ and In3+ in Aqueous Solution†,‡ , 1996 .

[14]  Stephen J Archibald,et al.  Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals. , 2014, Journal of labelled compounds & radiopharmaceuticals.

[15]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[16]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[17]  Lucía Gutiérrez,et al.  Biological applications of magnetic nanoparticles. , 2012, Chemical Society reviews.

[18]  Ajay Kumar Gupta,et al.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. , 2007, Nanomedicine.

[19]  Randy Wojcik,et al.  Initial tests of a prototype MRI-compatible PET imager , 2006 .

[20]  K. Sunassee,et al.  Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging. , 2011, Dalton transactions.

[21]  Yuxing Peng,et al.  Magnetic separation of polymer hybrid iron oxide nanoparticles triggered by temperature. , 2006, Chemical communications.

[22]  Michela Matteoli,et al.  Biocompatible nanocomposite for PET/MRI hybrid imaging , 2012, International journal of nanomedicine.

[23]  C. Anderson,et al.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.

[24]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[25]  Nicholas J Long,et al.  'Two is better than one'--probes for dual-modality molecular imaging. , 2009, Chemical communications.

[26]  J. Marco,et al.  Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents. , 2010, ACS nano.

[27]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[28]  Ciprian Catana,et al.  Bimodal MR-PET agent for quantitative pH imaging. , 2010, Angewandte Chemie.

[29]  Hao Hong,et al.  cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. , 2011, Biomaterials.

[30]  N. Dalal,et al.  Synthesis, magnetic characterization and sensing applications of novel dextran-coated iron oxide nanorods. , 2009, Chemistry of materials : a publication of the American Chemical Society.

[31]  Siegfried Kasper,et al.  Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET , 2008, NeuroImage.

[32]  L. Josephson,et al.  The effects of iron oxides on proton relaxivity. , 1988, Magnetic resonance imaging.

[33]  W R Harris,et al.  Thermodynamic binding constants for gallium transferrin. , 1983, Biochemistry.

[34]  M. Bartholomä.  Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography , 2012 .

[35]  Younan Xia,et al.  Inorganic nanoparticle-based contrast agents for molecular imaging. , 2010, Trends in molecular medicine.

[36]  S. Nie,et al.  Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity , 2008 .

[37]  S. Faulkner,et al.  A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions. , 2014, Dalton transactions.

[38]  É. Tóth,et al.  Kinetics of Ga(NOTA) formation from weak Ga-citrate complexes. , 2011, Inorganic chemistry.

[39]  Dimosthenis Stamopoulos,et al.  Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. , 2013, Current topics in medicinal chemistry.

[40]  R. D. Rosales,et al.  Potential clinical applications of bimodal PET-MRI or SPECT-MRI agents† , 2014 .

[41]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[42]  H. Acar,et al.  RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells , 2012, International journal of nanomedicine.

[43]  Synthesis of amino-group functionalized superparamagnetic iron oxide nanoparticles and applications as biomedical labeling probes , 2011 .

[44]  N. Long,et al.  The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging. , 2013, Chemical communications.

[45]  D. Koh.  Liver-specific contrast agents , 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.

[46]  P. Blower.  Towards molecular imaging and treatment of disease with radionuclides: the role of inorganic chemistry. , 2006, Dalton transactions.

[47]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[48]  Shuang Liu,et al.  Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. , 2001, Bioconjugate chemistry.

[49]  Wei-wei Wang,et al.  Synthesis and magnetic property of silica/iron oxides nanorods , 2010 .

[50]  R. Mewis,et al.  Biomedical applications of macrocyclic ligand complexes , 2010 .

[51]  Stephen J. Archibald,et al.  Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents. , 2014, Faraday discussions.